Dideoxyadenosine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Dideoxyadenosine
- DrugBank Accession Number
- DB17756
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 235.247
Monoisotopic: 235.106924679 - Chemical Formula
- C10H13N5O2
- Synonyms
- 2'-3'-dideoxyadenosine
- 2',3'-dideoxyadenosine
- 6-amino-9-(2',3'-dideoxy-.beta.-d-glycero-pentofuranosyl)purine
- 9-(2,3-dideoxy-.beta.-d-glycero-pentofuranosyl)-9h-purin-6-amine
- Dideoxyadenosine
- External IDs
- DDA
- NSC-98700
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Anti-Infective Agents
- Antihypertensive Agents
- Antimetabolites
- Antiviral Agents
- Cardiovascular Agents
- Deoxyadenosines
- Deoxyribonucleosides
- Dideoxynucleosides
- Heterocyclic Compounds, Fused-Ring
- Hydrocarbons, Chlorinated
- Hydrocarbons, Halogenated
- Immunologic Factors
- Immunosuppressive Agents
- Mitogens
- Mitosis Modulators
- Noxae
- Nucleic Acids, Nucleotides, and Nucleosides
- Nucleosides
- Purine Nucleosides
- Purines
- Toxic Actions
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4Q86AH641A
- CAS number
- 4097-22-7
- InChI Key
- WVXRAFOPTSTNLL-NKWVEPMBSA-N
- InChI
- InChI=1S/C10H13N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h4-7,16H,1-3H2,(H2,11,12,13)/t6-,7+/m0/s1
- IUPAC Name
- [(2S,5R)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl]methanol
- SMILES
- NC1=C2N=CN([C@H]3CC[C@@H](CO)O3)C2=NC=N1
References
- General References
- Not Available
- External Links
- ChemSpider
- 18879
- BindingDB
- 50004352
- ChEBI
- 91207
- ChEMBL
- CHEMBL23094
- ZINC
- ZINC000000040146
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -0.48 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 99.08 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 60.89 m3·mol-1 Chemaxon Polarizability 23.39 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at May 08, 2023 19:38 / Updated at May 09, 2023 23:23